By acting as partial agonists of PPARγ, falcarinol and its derivatives inhibit cancer cell proliferation and promote differentiation, suggesting that PPARγ activation is associated with reduced tumor growth and enhanced sensitivity to chemotherapy [12]. This evidence concerns the gene PPARG and neoplasm.